Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Drug Safety Oversight Board holds first meeting

Executive Summary

FDA will post a summary of the Drug Safety Oversight Board's inaugural meeting on its website on or around June 24, the agency says. The board convened June 17 to review organization and logistics, but did not discuss specific products, the agency said. The board will hold monthly meetings for the first six months of the board's inception (1"The Pink Sheet" May 23, 2005, p. 6)...

You may also be interested in...



FDA Names Drug Safety Board Members; First Meeting In Early Summer

Department of Veterans Affairs pharmacy benefit management advisor Chester Good brings experience with drug-related adverse event reporting to FDA's Drug Safety Oversight Board

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel